Q2042 Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Short descriptor: Tisagenlecleucel car-pos t
Look up Q2042 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
Q2042 is the HCPCS Level II code for Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Section
- Q: Temporary Codes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2019-01-01
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference Q2042 with the canonical source and edition:
Q2042 — Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q2042
Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q2042